176 related articles for article (PubMed ID: 12629954)
1. Biological perspectives. Aripiprazole: a third generation of antipsychotics begins?
Keltner NL; Johnson V
Perspect Psychiatr Care; 2002; 38(4):157-9. PubMed ID: 12629954
[TBL] [Abstract][Full Text] [Related]
2. Aripiprazole: does partial dopaminergic agonism translate into clinical benefits?
Crismon ML; DeLeon A; Miller AL
Ann Pharmacother; 2003 May; 37(5):738-40. PubMed ID: 12708954
[No Abstract] [Full Text] [Related]
3. Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism.
Naber D; Lambert M
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1213-9. PubMed ID: 15588748
[TBL] [Abstract][Full Text] [Related]
4. Aripiprazole: a new atypical antipsychotic drug.
Bowles TM; Levin GM
Ann Pharmacother; 2003 May; 37(5):687-94. PubMed ID: 12708948
[TBL] [Abstract][Full Text] [Related]
5. Aripiprazole.
Fleischhacker WW
Expert Opin Pharmacother; 2005 Oct; 6(12):2091-101. PubMed ID: 16197361
[TBL] [Abstract][Full Text] [Related]
6. [Aripiprazole: a new atypical antipsychotic drug].
Fischer B; Davids E; Gastpar M
Fortschr Neurol Psychiatr; 2004 Sep; 72(9):497-502. PubMed ID: 15365912
[TBL] [Abstract][Full Text] [Related]
7. Aripiprazole: what is the role of dopamine D(2) receptor partial agonism?
Kessler RM
Am J Psychiatry; 2007 Sep; 164(9):1310-2. PubMed ID: 17728411
[No Abstract] [Full Text] [Related]
8. [The antipsychotic drug aripiprazole (ABILIFY)].
Hirose T; Mamiya N; Yamada S; Taguchi M; Kameya T; Kikuchi T
Nihon Yakurigaku Zasshi; 2006 Nov; 128(5):331-45. PubMed ID: 17102579
[No Abstract] [Full Text] [Related]
9. Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic.
Keck PE; McElroy SL
Expert Opin Investig Drugs; 2003 Apr; 12(4):655-62. PubMed ID: 12665420
[TBL] [Abstract][Full Text] [Related]
10. Aripiprazole: efficacy and tolerability profile of a novel-acting atypical antipsychotic.
Buckley PF
Drugs Today (Barc); 2003 Feb; 39(2):145-51. PubMed ID: 12698209
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole.
McGavin JK; Goa KL
CNS Drugs; 2002; 16(11):779-86; discussion 787-8. PubMed ID: 12383035
[TBL] [Abstract][Full Text] [Related]
12. Worsened agitation with aripiprazole: adverse effect of dopamine partial agonism?
DeQuardo JR
J Clin Psychiatry; 2004 Jan; 65(1):132-3. PubMed ID: 14976671
[No Abstract] [Full Text] [Related]
13. Aripiprazole: pharmacology, efficacy, safety and tolerability.
Kinghorn WA; McEvoy JP
Expert Rev Neurother; 2005 May; 5(3):297-307. PubMed ID: 15938662
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
Stip E; Tourjman V
Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
Mamo D; Graff A; Mizrahi R; Shammi CM; Romeyer F; Kapur S
Am J Psychiatry; 2007 Sep; 164(9):1411-7. PubMed ID: 17728427
[TBL] [Abstract][Full Text] [Related]
16. Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology.
Davies MA; Sheffler DJ; Roth BL
CNS Drug Rev; 2004; 10(4):317-36. PubMed ID: 15592581
[TBL] [Abstract][Full Text] [Related]
17. [In vitro pharmacology of antipsychotics at human dopamine D2 and D3 receptors].
Tadori Y; Kobayashi H
Nihon Yakurigaku Zasshi; 2014 Dec; 144(6):265-71. PubMed ID: 25492361
[No Abstract] [Full Text] [Related]
18. Aripiprazole versus other atypical antipsychotics for schizophrenia.
Khanna P; Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; El-Sayeh HG; Leucht S
Cochrane Database Syst Rev; 2013 Feb; (2):CD006569. PubMed ID: 23450570
[TBL] [Abstract][Full Text] [Related]
19. Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents.
Prescrire Int; 2009 Dec; 18(104):251. PubMed ID: 20025091
[No Abstract] [Full Text] [Related]
20. Cochrane for clinicians. Aripiprazole vs. other atypical antipsychotics for schizophrenia.
Guirguis-Blake J
Am Fam Physician; 2010 Jun; 81(11):1335-6. PubMed ID: 20521753
[No Abstract] [Full Text] [Related]
[Next] [New Search]
